Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
Nature Biotechnology|July 31, 2019
Enhancing gene editing specificity by attenuating DNA cleavage kineticsJeffrey C Miller, Deepak P Patil, Danny F Xia, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2011
Discovery of amide replacements that improve activity and metabolic stability of a bis-amide smoothened antagonist hitMatthew L Brown, Wade Aaron, Richard J Austin, et al.
The European Respiratory Journal|November 23, 2023
The impact of outpatient versus inpatient management on health-related quality of life outcomes for patients with malignant pleural effusion: the OPTIMUM randomised clinical trialParthipan Sivakumar, Deirdre B Fitzgerald, Hugh Ip, et al.
The New England Journal of Medicine|March 7, 2014
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIVPablo Tebas, David Stein, Winson W Tang, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonistsBrian S Lucas, Wade Aaron, Songzhu An, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 28, 2024
Joint ERS/EACTS/ESTS clinical practice guidelines on adults with spontaneous pneumothoraxSteven Walker, Robert Hallifax, Sara Ricciardi, et al.
The New England Journal of Medicine|January 30, 2020
Conservative versus Interventional Treatment for Spontaneous PneumothoraxSimon G A Brown, Emma L Ball, Kyle Perrin, et al.
The European Respiratory Journal|May 28, 2024
Joint ERS/EACTS/ESTS clinical practice guidelines on adults with spontaneous pneumothoraxSteven Walker, Robert Hallifax, Sara Ricciardi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2015
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic MelanomaJoal D Beane, Gary Lee, Zhili Zheng, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2024
Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stabilityAndrew Mulato, Eric Lansdon, Ron Aoyama, et al.
Pageof 31